| Creon (pancrelipase delayed-release) / AbbVie, Eisai |
NCT00266721: Efficacy of Pancrelipase on Postprandial Belching and Bloating. |
|
|
| Completed | 3 | 45 | US | Pancrelipase (Creon) 2 tablets with each meal | Solvay Pharmaceuticals | Postprandial Bloating, Postprandial Belching, Postprandial Eructation | | 10/00 | | |
NCT00400842: A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency |
|
|
| Completed | 3 | 274 | Japan | SA-001, Placebo | Abbott | Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | 08/09 | 08/09 | | |
| Terminated | 3 | 34 | Europe | Creon 25000, Placebo | Abbott | Steatorrhea | 08/09 | 08/09 | | |
NCT00705978: Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis |
|
|
| Completed | 3 | 62 | RoW | Pancreatin, Placebo | Abbott Products, Datamap | Pancreatic Insufficiency | 05/10 | 05/10 | | |
NCT00401076: A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency |
|
|
| Completed | 3 | 80 | Japan | SA-001 | Abbott | Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy | 09/10 | 09/10 | | |
NCT01228643: Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs |
|
|
| Withdrawn | 3 | 0 | RoW | Pancreatic enzimes, Creon ® | Azidus Brasil | Chronic Renal Failure | 11/11 | 12/11 | | |
NCT01747330: Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency |
|
|
| Completed | 3 | 40 | RoW | Pancreatin, Creon micro | Abbott Products | Pancreatic Exocrine Insufficiency | 12/12 | 12/12 | | |
NCT02137382 / 2013-002819-10: A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis |
|
|
| Completed | 3 | 41 | Europe | Creon®, Creon N | Abbott | Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | 08/14 | 08/14 | | |
2004-005012-80: Double-blind, multicenter, randomized, placebo-controlled, parallel-group study to investigate the effect of Creon 25 000 Minimicrospheres on body mass index (BMI) in patients after gastrectomy. |
|
|
| Ongoing | 3 | 6 | Europe | Creon enterocapsule | Solvay Pharmaceuticals GmbH | Patients atleast 18 years old with total or subtotal gastrektomy. | | | | |
| Recruiting | 3 | 60 | RoW | Creon® 25000, Creon® 10000 | Abbott | Pancreatic Insufficiency | 04/22 | 04/22 | | |
NCT01012908: Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency |
|
|
| Unknown status | 2/3 | 25 | RoW | Norzyme - Bergamo, Creon | Azidus Brasil | Pancreatic Insufficiency | 04/10 | 06/11 | | |
PB-SAM, NCT04542473: Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children |
|
|
| Active, not recruiting | 2/3 | 400 | RoW | Pancreatic Enzyme, CREON, Ursodeoxycholic acid, UDCAMENT, Pancreatic Enzyme placebo, Placebo-PE, Ursodeoxycholic acid placebo, Placebo-UA | University of Oxford, University of Amsterdam, University of Toronto, University of Washington, Oregon Health and Science University, Kenya Medical Research Institute, Queen Elizabeth Central Hospital, Blantyre, Malawi, Makerere University, KEMRI-Wellcome Trust Collaborative Research Program, International Centre for Diarrhoeal Disease Research, Bangladesh | SEPSIS, MALNUTRITION, CHILD | 10/23 | 06/24 | | |
